Current issues regarding Complementary and Alternative Medicine (cam) in the United States - Part 2: Regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements

P and T

Volumn 35, Issue 9, 2010, Pages 514-522

  Ventola, C Lee ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CYCLOSPORIN; DIGOXIN; FEXOFENADINE; GLUCOSAMINE; GRAPE SEED EXTRACT; IMATINIB; INDINAVIR; IRINOTECAN; KAVA; METHADONE; NATURAL PRODUCT; ORAL CONTRACEPTIVE AGENT; SIMVASTATIN; TACROLIMUS; VALERIAN; WARFARIN; YOHIMBINE;

AESCULUS HIPPOCASTANUM; ALTERNATIVE MEDICINE; BERRY; BLEEDING; CHINESE MEDICINE; CIMICIFUGA RACEMOSA; CRANBERRY; DIET SUPPLEMENTATION; DRUG MECHANISM; ECHINACEA; EDEMA; ELEUTHEROCOCCUS SENTICOSUS; EPHEDRA; EVENING PRIMROSE; EYE IRRITATION; FOOD DRUG INTERACTION; GARLIC; GINGER; GINKGO BILOBA; GINSENG; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; HYPOKALEMIA; INTEGRATIVE MEDICINE; MEDICAL PRACTICE; NEPHROTOXICITY; PATIENT COUNSELING; REVIEW; SABAL; SAFETY; SILYBUM MARIANUM; SOYBEAN; TEA; TERATOGENESIS; TOXICITY; UNITED STATES;

EID: 77957158309     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Dunn JD, Cannon HE, Lewis T, Shane-McWorter L. Development of a complementary and alternative medicine (CAM) pharmacy and therapeutics (P&T) subcommittee and CAM guide for providers. J Manag Care Pharm 2005;11(3):252-258.
2. Waldman SA, Terzic A. Pharmacology and Therapeutics: Principles to Practice. Philadelphia: Elsevier/WB Saunders; 2008:1237-1243.
3. Bazzie KL, Witmer DR, Pinto B, et al. National survey of dietary supplement policies in acute care facilities. Am J Health Syst Pharm 2006;63(1):65-70. (Pubitemid 43062530)
4. Boyer EW. Issues in the management of dietary supplement use among hospitalized patients. Int J Med Toxicol 2005;1(1):30-34.
5. Alternative medicine spending soars. The Washington Post, July 30, 2009. Available at: http://voices.washingtonpost.com/checkup/2009/07/alternative- medicine-spending.html. Accessed July 16, 2010.
6. Gardiner P, Phillip RS, Kemper K, et al. Dietary supplements: Inpatient policies in U.S. children's hospitals. Pediatrics 2008;121(4):e775-e781.
7. Kantor M. The role of rigorous scientific evaluation in the use and practice of complementary and alternative medicine. J Am Coll Radiol 2009;6(4):254-262.
8. American Society of Health-System Pharmacists. ASHP statement on the use of dietary supplements. Am J Health Syst Pharm 2004;61:1707-1711.
9. Cohen KR, Cerone P, Ruggiero R. Complementary/alternative medicine use: Responsibilities and implications for pharmacy services. P&T 2002;27(9):440-446.
10. Micozzi, MS. Integrative medicine in pharmacy and therapeutics. P&T 2003;28(10):666-672.
11. National Center for Complementary and Alternative Medicine (NCCAM). Available at: http://nccam.nih.gov. Accessed July 16, 2010.
12. FDA. Dietary Supplement Health and Education Action of 1994. Available at: www.fda.gov/opacom/laws/dshea.html. Accessed July 16, 2010.
13. Kwan D, Hirschkorn K, Boon H. U.S. and Canadian pharmacists' attitudes, knowledge, and professional practice behaviors toward dietary supplements: A systematic review. BMC Complement Altern Med 2006;6(31):1-10.
14. McHughes M, Timmerman B. A review of the use of CAM therapy and the sources of accurate and reliable information. J Manag Care Pharm 2005;11(8):695-703.
15. Saini A, Birrer R, Harghel C, et al. Polypharmacy, complementary and alternative medicine in the elderly. P&T 2001;26(12):616-621.
16. Cohen MH, Ruggie M, Micozzi MS. The Practice of Integrative Medicine: A Legal and Operational Guide. Springer; 2006:224.
17. Vohra S, Feldman K, Johnston B, et al. Integrating complementary and alternative medicine into academic medical centers: Experience and perceptions of nine leading centers in North America. BMC Health Serv Res 2005;5(78):1-7.